Valeo Financial Advisors LLC Sells 8,961 Shares of CVS Health Co. (NYSE:CVS)

Valeo Financial Advisors LLC reduced its position in shares of CVS Health Co. (NYSE:CVS) by 18.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 40,215 shares of the pharmacy operator’s stock after selling 8,961 shares during the period. Valeo Financial Advisors LLC’s holdings in CVS Health were worth $3,208,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Atticus Wealth Management LLC grew its position in CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 219 shares during the last quarter. USA Financial Formulas increased its stake in shares of CVS Health by 573.2% in the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. bought a new position in shares of CVS Health in the fourth quarter valued at about $32,000. Creekmur Asset Management LLC acquired a new position in CVS Health during the 4th quarter worth about $34,000. Finally, Steph & Co. increased its position in CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 288 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on CVS. TD Cowen cut shares of CVS Health from a “buy” rating to a “hold” rating and decreased their price target for the company from $99.00 to $59.00 in a research note on Tuesday, May 7th. Truist Financial reissued a “buy” rating and issued a $66.00 target price (down from $90.00) on shares of CVS Health in a research note on Thursday, May 2nd. Barclays decreased their price target on CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a report on Thursday, May 2nd. Cantor Fitzgerald reiterated a “neutral” rating and issued a $58.00 price objective on shares of CVS Health in a research report on Wednesday, June 12th. Finally, Argus reduced their target price on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, May 8th. Eleven equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $75.05.

Insider Transactions at CVS Health

In other CVS Health news, Director Edward J. Ludwig bought 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was acquired at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the transaction, the director now owns 21,630 shares in the company, valued at $1,165,424.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.24% of the stock is currently owned by insiders.

CVS Health Stock Down 1.4 %

Shares of CVS stock traded down $0.82 during trading hours on Wednesday, hitting $56.70. 5,366,799 shares of the company were exchanged, compared to its average volume of 11,982,148. The company has a market capitalization of $71.18 billion, a PE ratio of 10.07, a PEG ratio of 0.56 and a beta of 0.52. CVS Health Co. has a 52 week low of $52.77 and a 52 week high of $83.25. The business has a 50 day moving average of $59.12 and a two-hundred day moving average of $69.90. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The firm had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The business’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the firm earned $2.20 earnings per share. Analysts anticipate that CVS Health Co. will post 7.02 earnings per share for the current fiscal year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.